Related Experiment Video

Updated: Jul 9, 2026

Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays
07:42

Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays

Published on: September 19, 2018

[The role of oncogenic tyrosine kinases in the cellular response to anticancer therapy]

Artur Słupianek1, Dariusz Pytel, Ireneusz Majsterek

  • 1Katedra Mikrobiologii i Immunologii, Temple University School of Medicine, Philadelphia, PA, USA.

Postepy Higieny I Medycyny Doswiadczalnej (Online)
|December 22, 2007
PubMed

Insights

Oncogenic tyrosine kinases (OTKs) drive cancer growth by promoting cell proliferation and resistance to therapy. Targeting OTKs could lead to new cancer treatments by disrupting these critical cellular processes.

Area of Science:

  • Molecular Oncology
  • Cancer Cell Biology
  • DNA Repair Mechanisms

Context:

  • Oncogenic tyrosine kinases (OTKs) are frequently overexpressed in malignant tumors, driving cancer progression.
  • OTKs promote tumor growth by stimulating cell proliferation, inhibiting apoptosis, and conferring resistance to therapies.
  • These kinases influence cellular responses to treatment through various mechanisms, including cell cycle arrest and DNA repair modulation.

Purpose:

  • To elucidate the multifaceted roles of oncogenic tyrosine kinases (OTKs) in cancer development and treatment resistance.
  • To investigate how OTKs modulate cellular processes such as apoptosis, cell cycle progression, and DNA repair.
  • To understand the specific DNA repair pathways, including base excision repair (BER), nucleotide excision repair (NER), and double-strand break repair (DSB) via non-homologous end-joining (NHEJ) and homologous recombination repair (HHR), that are influenced by OTKs.

Summary:

  • OTKs promote cancer by enhancing cell proliferation, blocking apoptosis, and inducing drug resistance.
  • OTKs elevate reactive oxygen species (ROS), leading to DNA damage, and activate specific DNA repair pathways like homologous recombination repair (HHR) via RAD51 and BLM.
  • Understanding these OTK-mediated mechanisms is crucial for developing targeted cancer therapies.

Impact:

  • This research provides insights into the complex molecular mechanisms underlying cancer driven by OTKs.
  • Identifying key pathways modulated by OTKs, such as DNA repair and apoptosis, opens avenues for novel therapeutic strategies.
  • Targeting OTKs and their downstream effectors offers a promising approach for overcoming treatment resistance and improving patient outcomes.

More Related Videos

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia10:49

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

Published on: September 18, 2013

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence10:09

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence

Published on: January 7, 2019

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...